NCT05079178

Brief Summary

Very little is known about the impact on the newborn of late pre-partum maternal SARS-CoV-2 infection. Care without separation of the mother and her newborn with continued breastfeeding has been advocated in France and by the WHO but is being debated in some countries. Assessment of the development of newborns in their first month of life with this strategy associated with close and secure follow-up. Importance of reporting the potential benefits / risks of this treatment to guide the care of newborns in a persistent epidemic context in a particularly affected region.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

October 14, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 15, 2021

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2021

Completed
Last Updated

November 18, 2021

Status Verified

October 1, 2021

Enrollment Period

1.4 years

First QC Date

October 14, 2021

Last Update Submit

November 17, 2021

Conditions

Keywords

COVID-19SARS-COV-2Newborns of COVID-19 mothersCOVID-19 PandemicCOVID-19 Virus Disease

Outcome Measures

Primary Outcomes (1)

  • Retrospective description of the care and follow-up in the first month of life of newborns in level III services in Alsace from mothers with COVID-19

    Files analysed retrospectively from March 01, 2020 to Jun 30, 2020 will be examined]

Eligibility Criteria

Age1 Day - 1 Year
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Newborns born between March 1 and June 30, 2020 to COVID 19 from positive mothers in Strasbourg University Hospital or Mulhouse Hospital.

You may qualify if:

  • Newborns born between March 1 and June 30, 2020 to COVID 19
  • From positive mothers in Strasbourg University Hospital or Mulhouse Hospital.
  • Parents' non-opposition to the analysis of hospitalization data for children contained in the medical file

You may not qualify if:

  • \- Parents' opposition to the analysis of hospitalization data for children contained in the medical file

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Médecine et Réanimation du Nouveau-né - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2021

First Posted

October 15, 2021

Study Start

June 1, 2020

Primary Completion

October 31, 2021

Study Completion

October 31, 2021

Last Updated

November 18, 2021

Record last verified: 2021-10

Locations